Shots: 4D to receive up front in cash for each indication, ~$347.5M as option exercise fee, development & commercialization milestones with royalties on sales of licensed product derived from the […]readmore
Tags : Live Biotherapeutics
Shots: NIH has launched LUCA Biologics in Cambridge, Massachusetts focusing on women’s health by initially targeting UTI with its anticipated clinical study and initiation of recruitment of patients in H2’19 […]readmore